Thapsigargin enhances camptothecin-induced apoptosis in cardiomyocytes

Pharmacology and Toxicology

Volumn 85, Issue 5, 1999, Pages 212-220

  Kong, Jennifer Y ^a   Rabkin, Simon W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIUM; CAMPTOTHECIN; DNA FRAGMENT; DNA TOPOISOMERASE INHIBITOR; THAPSIGARGIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CARDIOTOXICITY; CHICK EMBRYO; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032732751     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb02011.x     Document Type: Article

References (58)

1. Bednar, R. J.: The twist, writhe, and overall shape of supercoiled DNA change during counterion-induced transition from a loosely to a tightly interwound suprahelix. Possible implications for DNA structure in vivo. J. Mol. Biol. 1984, 235, 825-847.
2. +2-EGTA solutions. Amer. J. Physiol. 1982, 242, C404-C408.
3. Borde, V. & M. Duguet: The mapping of DNA topoisomerase sites in vivo: a tool to enlight the functions of topoisomerases. Biochimie 1998, 80, 223-233.
4. Bonfoco, E., D. Krainic, M. Ankarcrona, P. Nicotera & S. Ipton: Apoptosis and necrosis: Two distinct events induced respectively by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. 1995, 92, 7162-7166.
5. Burgoyne, L. A., D. R. Hewish & J. Mobbs: Mammalian chromatin substructures studies with the calcium-magnesium endonuclease and 2 dimensional polyacrylamide gel electrophoresis. Biochem. J. 1974, 143, 67-72.
6. Champoux J. J.: Domains of human topoisomerase I and associated functions. Prog. Nucleic Acid Res. Mol. Biol. 1998, 60, 111-132.
7. Cozarelli N. R. & J. C. Wang: DNA topology and its biological Effects. Cold Spring Harbor Laboratory, Cold Spring Harbour, New York 1990.
8. Darzynkiewicz, Z., G. Juan, W. Gorczyca, T. Murakami & F. Traganos: Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 1997, 27, 1-20.
9. Eastman, A. & M. A. Barry: The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? Cancer Invest. 1992, 10, 229-240.
10. Eguchi, Y., D. L. Ewert & Y. Tsujimoto: Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissue including lymphoid and neuronal organs in adult and embryo. Nucleic Acids Res. 1992, 220, 4187-4192.
11. El Alaoui, S., S. Mian, J. Lawry, G. Quash & Griffin: Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis). FEBS Lett. 1992, 311, 174-178.
12. Fisher, D. J., S. Philips & T. McQuinn: Regulation of SERCA 2 expression by thyroid hormone in cultured chick embryo cardiomyocytes. Amer. J. Physiol. 1996, 270, H638-H644.
13. Froelich-Ammon, S. J. & N. Osheroff: Topoisomerase poisons: Harnessing the dark side of enzyme mechanism. J. Biol. Chem. 1995, 270, 21429-21432.
14. Furuya, Y., P. Lundmo, A. D. Shart, D. L. Gill & J. T. Isaacs. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res. 1994, 54, 6167-6175.
15. +2-dependent adenosine triphosphatase of sarcoplasmic reticulum in cell cultures of embryonic chick hearts. J. Biol. Chem. 1979, 254, 7604-7610.
16. Hortobagyi, G. N.: Anthracyclines in the treatment of cancer. An overview. Drugs 1997, 54, Suppl 4, 1-7.
17. Horwitz, S. B., C. K. Chang & A. P. Grollman: Studies on camptothecin. Effects on nucleic acid and protein synthesis. Mol. Pharmacol. 1971, 7, 632-644.
18. Huet, O., J. M. Petit, M. H. Ratinaud & R. Julien: NADH-dependent dehydrogenase activity estimation by flow cytometric analysis of 3-(4,5-dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. Cytometry 1992, 13, 532-539.
19. Inesi, G., D. Lewis, C. Sumbilla, A. Nandi, C. Strock, K. W. Huff, T. B. Rogers, D. C. Johns, P. D. Kessler & C. P. Ordahl. Cell-specific promoter in adenovirus vector for transgenic expression of SERCAI ATPase in cardiac myocytes. Amer. J. Physiol. 1998, 274, C645-653.
20. James, T. N.: Normal and abnormal consequences of apoptosis in the human heart. Ann. Rev. Physiol. 1998, 60, 309-325.
21. Janczewski, A. M. & E. G. Lakatta: Buffering of calcium influx by sarcoplasmic reticulum during the action potential in guinea-pig ventricular myocytes. J. Physiol. 1993, 471, 343-363.
22. Kaneko, Y. & A. Tsukamoto: Thapsigargin-induced persistent intracellular calcium pool depletion and apoptosis in human hepatoma cells. Cancer Lett. 1994, 79, 147-155.
23. Katz, A. M.: Molecular biology of calcium channels in the cardiovascular system. Amer. J. Cardiol. 1997, 80, 171-221.
24. Kawano, S. & R. L. DeHaan: Developmental changes in the calcium currents in embryonic chick ventricular myocytes. J. Membrane Biol. 1991, 120, 17-28.
25. Kessel, D.: Effects of camptothecin on RNA synthesis in leukemia L1210 cells. Biochim. Biophys. Acta 1971, 246, 225-232.
26. +2 pump protein of reticulum J. Biol. Chem. 266, 22912-22918.
27. Leist, M., F. Gantner, Bohlinger, P. G. Germann, G. Tiegs & A. Wendel: Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 1994, 153, 1778-1788.
28. Lin, X. S., S. R. Denmeade, L. Cisek & J. T. Isaacs: Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin. Prostate 1997, 33, 201-207.
29. MacLellan, W. R. & M. D. Schneider: Death by design. Programmed cell death in cardiovascular biology and disease. Circ. Res. 1997, 81, 137-144.
30. Malonne, H. & G. Atassi: DNA topoisomerase targeting drugs: mechanisms of action and perspectives. Anti-Cancer Drugs 1997, 8, 811-822.
31. Marks, A. R.: Intracellular calcium-release channels: regulators of cell life and death. Amer. J. Physiol. 1997, 272, H597-605.
32. McConkey, D. J. & S. Orrenius: The role of calcium in the regulation of apoptosis. J. Leukocyte Biol. 1996, 59, 775-783.
33. Mercadier, J. J., P. Bouveret, L. Gorza, S. Schiaffino, W. A. Clark, R. Zak, B. Swynghedauw & K. Schwartz: Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ. Res. 1983, 53, 52-62.
34. Mosmann, T.: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983, 5, 55-63.
35. Nicotera, P. & S. Orrenius: The role of calcium in apoptosis. Cell Calcium 1998, 23, 173-180.
36. Onishi, Y., S. Hashimoto & H. Kizaki: Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 1998, 215, 453-459.
37. +2-ATPase inhibitors upon IL-3 deprivation. Exp. Cell Res. 1996, 228, 92-97.
38. Pommier, Y.: Diversity of DNA topoisomerases I and inhibitors. Biochimie 1998, 80, 255-270.
39. 45Ca-Efflux in embryonic heart and its modification by caffeine and ryanodine. J. Dev. Physiol. 1992, 18, 285-293.
40. Rabkin, S. W.: Lisinopril increases the recovery during reoxygenation and resistance to oxidative damage in cardiomyocytes. Eur. J. Pharmacol. 1993, 238, 81-88.
41. Rabkin, S. W. & P. Sunga: The effect of doxorubicin (adriamycin) on cytoplasmic microtubule system in cardiac cells. J. Mol. Cell. Cardiol. 1987, 19, 1073-1083.
42. +2 homeostasis in cardiac cells. Biosci. Rep. 1995, 15, 341-349.
43. Rothenberg, M. L.: Topoisomerase I inhibitors: review and update. Ann. Oncol. 1997, 8, 837-855.
44. Sabbah, H. N. & V. G. Sharov: Apoptosis in heart failure. Prog. Cardiovasc. Dis. 1998, 40, 549-562.
45. Scheid, M. P., R. W. Lauener & V. Duronio: Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem. J. 1995, 312, 159-162.
46. Schulz-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg & M. E. Peter: Apoptosis signaling by death receptors. Eur. J. Biochem. 1998, 254, 439-459.
47. Singal, P. K. & N. Iliskovic. Doxorubicin-induced cardiomyopathy. New Engl J. Med. 1998, 339, 900-905.
48. Sommer, J. K. & E. A. Johnson: Cardiac muscle: A comparative ultrastructural study with special reference to frog and chicken hearts. Z. Zellforsch. 1969, 98, 437-468.
49. Staunton, M. J. & E. F. Gaffney: Apoptosis: basic concepts and potential significance in human cancer. Arch. Pathol. Lab. Med. 1998, 122, 310-319.
50. Tazi, J., F. Rossi, E. Labourier, I. Gallouzi, C. Brunel & E. Antoine: DNA topoisomerase I: customs officer at the border between DNA and RNA worlds? J. Mol. Med 1997, 75, 786-800.
51. +2]i regulation in apoptosis, oncosis, and necrosis. Biochim. Biophys. Acta 1996, 1313, 173-178.
52. Wang, J. C.: DNA topoisomerases as targets of therapeutics: an overview. Adv. Pharmacol. (New York) 1994, 29A, 1-19.
53. Wang, J. C.: Variation of the average rotation angle of the DNA helix & the suprahelical turns of covalently closed cyclic lambda DNA. J. Mol. Biol. 1969, 43, 25-39.
54. Weichert, H., I. Blechschmidt, S. Schroder & H. Ambrosius: The MTT-assay as a rapid test for cell proliferation and cell killing: application to human peripheral blood lymphocytes (PBL). Allergie und Immunologie 1991, 37, 139-144.
55. +2 uptake in several cardiac preparations. Biomed. Biochim. Acta 1987, 46, S375-S381.
56. Wyllie, A. H.: Apoptosis and the regulation of cell number in normal and neoplastic tissues: an overview. Cancer and Metastasis 1992, 11, 95-103.
57. Zamai, L., E. Falcieri, G. Marhefka & M. Vitale: Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentatioin. Cytometry 1996, 23, 303-311.
58. Zechiedrich, L. & Osheroff, N.: Eucaryotic topoisomerases recognizes nucleic acid topology by preferentially interacting with DNA crossovers. EMBO J. 1990, 9, 4555-4562.